(Q45020579)

8 December 2017

title

Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys (English)

1 reference

8 December 2017

Jerry J Buccafusco

1

1 reference

8 December 2017

Alvin V Terry

series ordinal

2

1 reference

8 December 2017

publication date

1 January 2004

1 reference

Journal of Molecular Neuroscience

8 December 2017

published in

1 reference

8 December 2017

volume

24

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

85-91

1 reference

https://scigraph.springernature.com/pub.10.1385/jmn:24:1:085

8 December 2017

exact match

0 references

cites work

[Long-term treatment of Alzheimer's disease: followup of a cohort of 255 patients treated with lacrine for four years]

1 reference

12 December 2020

Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations

1 reference

12 December 2020

Acetylcholine, aging, and Alzheimer's disease

1 reference

12 December 2020

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

1 reference

12 December 2020

Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys.

1 reference

12 December 2020

Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease.

1 reference

12 December 2020

Cholinesterase inhibitors stabilize Alzheimer's disease

1 reference

12 December 2020

Cholinergic enhancement and increased selectivity of perceptual processing during working memory.

1 reference

12 December 2020

Simulation of cortical cholinergic deficits--a novel experimental approach to study pathogenetic aspects of Alzheimer's disease

1 reference

12 December 2020

Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys.

1 reference

12 December 2020

The older rabbit as an animal model: implications for Alzheimer's disease

1 reference

12 December 2020

Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys.

1 reference

12 December 2020

Multiple central nervous system targets for eliciting beneficial effects on memory and cognition.

1 reference

12 December 2020

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

1 reference

12 December 2020

Facilitation of memory performance by a novel muscarinic agonist in young and old rats.

1 reference

12 December 2020

Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans.

1 reference

12 December 2020

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

1 reference

12 December 2020

Transgenic mouse models of Alzheimer's disease

1 reference

12 December 2020

Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys.

1 reference

12 December 2020

Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.

1 reference

12 December 2020

Impact of study design and patient population on outcomes from cholinesterase inhibitor trials

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:24:1:085

1 reference

Dimensions Publication ID

8 December 2017

1008325623

0 references

1 reference